improving Oncology analysis with built-in KRAS Assay products and services and RAS Assays
within the rapidly evolving subject of oncology analysis, exact and productive mutation screening is vital for producing qualified therapies. The KRAS Services Platform performs a pivotal role Within this landscape by presenting thorough methods for KRAS mutation profiling and Evaluation. KRAS mutations, found in about 95% of RAS-linked oncogenic a